MOAN 发表于 2025-3-23 09:55:56

http://reply.papertrans.cn/1/96/9562/9562-11.png

遗产 发表于 2025-3-23 14:09:15

Submitted on: 28 July 2012.
Revised on: 24 September 2012.
Accepted on: 03 November 2012.

___________________Expert Review of Clinical Pharmacology

不透气 发表于 2025-3-23 18:14:45

Submitted on: 23 April 2004.
Revised on: 05 June 2004.
Accepted on: 04 July 2004.

___________________Expert Review of Clinical Pharmacology

反感 发表于 2025-3-24 02:09:48

http://reply.papertrans.cn/1/96/9562/9562-14.png

legislate 发表于 2025-3-24 04:15:01

http://reply.papertrans.cn/1/96/9562/9562-15.png

triptans 发表于 2025-3-24 09:59:19

http://reply.papertrans.cn/1/96/9562/9562-16.png

弹药 发表于 2025-3-24 11:28:56

http://reply.papertrans.cn/1/96/9562/9562-17.png

一小块 发表于 2025-3-24 16:06:26

http://reply.papertrans.cn/1/96/9562/9562-18.png

Ataxia 发表于 2025-3-24 21:14:42

Submitted on: 21 May 2015.
Revised on: 25 August 2015.
Accepted on: 05 October 2015.

___________________Expert Review of Clinical Pharmacology

1FAWN 发表于 2025-3-24 23:15:32

Submitted on: 02 April 2011.
Revised on: 29 May 2011.
Accepted on: 27 July 2011.

___________________Expert Review of Clinical Pharmacology
页: 1 [2] 3 4
查看完整版本: SCIE期刊Expert Review of Clinical Pharmacology 2024/2025影响因子:3.643 (EXPERT REV CLIN PHAR) (1751-2433). (PHARMACOLOGY & PH